Efficacy of rabies biologics against new lyssaviruses from Eurasia.
about
Diversity and epidemiology of Mokola virusLagos bat virus, South AfricaSerological Evidence of Lyssaviruses among Bats on Southwestern Indian Ocean IslandsBats: important reservoir hosts of emerging viruses.Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxisLyssavirus-reactive antibodies in Swedish batsCross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species.Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.Early diagnosis of Irkut virus infection using magnetic bead-based serum peptide profiling by MALDI-TOF MS in a mouse model.Quantifying antigenic relationships among the lyssaviruses.Isolation of Irkut virus from a Murina leucogaster bat in ChinaBats, emerging infectious diseases, and the rabies paradigm revisited.A universal real-time assay for the detection of Lyssaviruses.Isolation of Lagos bat virus from water mongooseLyssavirus surveillance in bats, BangladeshVaccines for lyssaviruses other than rabies.Lagos bat virus in Kenya.Development in Immunoprophylaxis against Rabies for Animals and HumansProduction, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans.Lyssaviruses.Possible emergence of West Caucasian bat virus in AfricaTravel vaccination for rabies.Evaluation of rabies biologics against Irkut virus isolated in China.Feline rabies. ABCD guidelines on prevention and management.Antigenic and genetic characterization of a divergent African virus, Ikoma lyssavirus.Emerging tropical diseases in Australia. Part 3. Australian bat lyssavirus.Molecular epidemiology of bat lyssaviruses in Europe.Twenty years of active bat rabies surveillance in Germany: a detailed analysis and future perspectives.Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison.Protection of bats (Eptesicus fuscus) against rabies following topical or oronasal exposure to a recombinant raccoon poxvirus vaccine.Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2.Pathogenicity of different rabies virus isolates and protection test in vaccinated mice.Lagos bat virus virulence in mice inoculated by the peripheral route.Cross-protective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes.Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses.Maternal antibody and the maintenance of a lyssavirus in populations of seasonally breeding African bats.Pathogenicity and Immunogenicity of Recombinant Rabies Viruses Expressing the Lagos Bat Virus Matrix and Glycoprotein: Perspectives for a Pan-Lyssavirus VaccineSero-Surveillance of Lyssavirus Specific Antibodies in Nigerian Fruit Bats (Eidolon helvum)Lagos Bat Virus Infection Dynamics in Free-Ranging Straw-Colored Fruit Bats (Eidolon helvum)
P2860
Q21092275-F6ABEC1B-D19D-4196-B4E6-D618D971B878Q24627758-48987EC3-BAF1-47A4-A454-A4AAE3C6790DQ27331298-D2C5DDC8-D462-4405-9B1F-260D23267A77Q27473464-FF72F75B-B74E-43C1-AE78-186E98C9A0C9Q28601417-2EC8E1D5-498B-4F0B-B4FD-95DC95CF2607Q28817431-6C7EE767-1506-4742-91E7-05FEF36C5A68Q30875451-F4A065E5-02DC-45BE-9486-8F4AF245C28BQ33514828-A2AE7029-823B-4117-88BE-94DF8D0DED25Q33580345-EC45BE72-AFBD-4330-9DB8-D4809BC87826Q34296085-92624B07-92B8-4FA8-9F5B-63402482E2FFQ34626120-28BAA778-8D8C-4AF0-9916-5DD5856C86BDQ35200044-D02D9997-4AA4-491E-A202-DF6A5B1B593BQ35317519-1CC53FF5-091B-4E6B-B944-828E4A72DB57Q35793622-B6810181-2EF5-4E7C-98EF-87D09A10A220Q35793893-2E14A815-DC17-4718-A4A9-A124926F4417Q36238718-D1BA248B-364A-4A21-B7A6-CABF5E9BF188Q36539910-0704427B-F4E8-4CA3-B88C-9CD538488E2FQ36571288-A74EC9A5-546C-4E15-A1D6-E6B562D7AF2BQ36788708-F366F4BA-6C84-4EDB-8BBB-FF4CAEC29788Q37011499-E37BD22F-64E7-40A7-8C38-7CA2DAFADAF2Q37080835-6FD4ADCF-2BF1-4507-8C3B-622506D805BDQ37194785-BB25CD7E-E14C-40F9-B1C0-A84EFBE6C2B8Q37470270-8BE92D2A-8638-46D9-9F91-E87A2FB23D2DQ37500852-581ABA5E-64D2-410D-AC0E-523516021028Q37698084-16200729-5763-47C5-95A9-433596D21A15Q37818630-C4FA68A7-7C05-469E-9074-5778853AD366Q38039471-62835A06-993A-459E-94D3-09F99AC9A1A9Q39355076-8AD58A05-EB6B-4360-90E2-9B4E131E3E91Q39946439-6CED03FE-3867-4013-9EF2-44EB213B60D2Q41924718-8F121D6B-4DD6-4509-A450-FA9FBD90F7EDQ41926166-F1DD175A-9442-494E-A5A1-5F3BA2E8DBA1Q45371488-A762B8AC-F399-457F-BF7E-E82521C92CE9Q45387329-6445864B-003D-46D1-8FFD-EE031D520E16Q46214294-B303DE32-B37C-41A4-8673-0794A8D24FCFQ54255407-CB8D39DB-5661-444E-A466-6B563DEFAFC9Q55404565-F562D3A5-58AB-4738-A0A1-D505A120CF78Q56967894-864DFE8F-2999-40EE-BC31-A1D16BE2C6E5Q57152902-510A1353-2FA1-444B-93E9-A59C89B7A3B5Q57152936-9D93E745-C074-4748-9545-35DC32F14715
P2860
Efficacy of rabies biologics against new lyssaviruses from Eurasia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Efficacy of rabies biologics against new lyssaviruses from Eurasia.
@en
Efficacy of rabies biologics against new lyssaviruses from Eurasia.
@nl
type
label
Efficacy of rabies biologics against new lyssaviruses from Eurasia.
@en
Efficacy of rabies biologics against new lyssaviruses from Eurasia.
@nl
prefLabel
Efficacy of rabies biologics against new lyssaviruses from Eurasia.
@en
Efficacy of rabies biologics against new lyssaviruses from Eurasia.
@nl
P2093
P50
P1433
P1476
Efficacy of rabies biologics against new lyssaviruses from Eurasia.
@en
P2093
Cathleen A Hanlon
Ivan V Kuzmin
Jamie S Manangan
P356
10.1016/J.VIRUSRES.2005.03.009
P577
2005-04-26T00:00:00Z